Hims & Hers Health (NYSE:HIMS) Shares Down 1.8% on Insider Selling

Hims & Hers Health, Inc. (NYSE:HIMS) shares fell 1.8% during mid-day trading on Tuesday following insider selling activity. The stock traded as low as $55.76 and last traded at $55.86. 12,367,363 shares changed hands during mid-day trading, a decline of 40% from the average session volume of 20,724,897 shares. The stock had previously closed at $56.86.

Specifically, insider Michael Chi sold 5,100 shares of the business’s stock in a transaction on Friday, June 6th. The stock was sold at an average price of $56.00, for a total value of $285,600.00. Following the sale, the insider now owns 256,580 shares of the company’s stock, valued at approximately $14,368,480. The trade was a 1.95% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Wall Street Analyst Weigh In

Several equities research analysts have commented on HIMS shares. Citigroup reiterated a “sell” rating and issued a $30.00 price target (up from $25.00) on shares of Hims & Hers Health in a research report on Tuesday, May 6th. Piper Sandler reaffirmed a “neutral” rating and issued a $39.00 price target (up previously from $35.00) on shares of Hims & Hers Health in a report on Tuesday, May 6th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Hims & Hers Health in a research note on Wednesday, May 7th. Needham & Company LLC lifted their price objective on shares of Hims & Hers Health from $61.00 to $65.00 and gave the stock a “buy” rating in a research report on Wednesday, June 4th. Finally, Bank of America increased their target price on Hims & Hers Health from $22.00 to $26.00 and gave the company an “underperform” rating in a report on Tuesday, April 29th. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, Hims & Hers Health has a consensus rating of “Hold” and a consensus target price of $38.00.

Hims & Hers Health Price Performance

The company has a market cap of $12.50 billion, a price-to-earnings ratio of 126.95 and a beta of 2.09. The firm has a fifty day simple moving average of $42.75 and a 200 day simple moving average of $37.55.

Hims & Hers Health (NYSE:HIMS) last announced its earnings results on Monday, May 5th. The company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.12 by $0.08. Hims & Hers Health had a net margin of 8.19% and a return on equity of 10.97%. The firm had revenue of $586.01 million for the quarter, compared to the consensus estimate of $535.21 million. During the same quarter last year, the firm posted $0.05 EPS. The business’s quarterly revenue was up 110.7% on a year-over-year basis. Analysts expect that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current year.

Institutional Trading of Hims & Hers Health

Several hedge funds have recently added to or reduced their stakes in the business. Strs Ohio acquired a new position in shares of Hims & Hers Health during the first quarter worth approximately $1,469,000. Kilter Group LLC boosted its holdings in Hims & Hers Health by 1.0% in the 1st quarter. Kilter Group LLC now owns 43,989 shares of the company’s stock valued at $1,300,000 after purchasing an additional 450 shares during the period. Geneos Wealth Management Inc. bought a new stake in Hims & Hers Health in the 1st quarter valued at $30,000. Intech Investment Management LLC grew its position in Hims & Hers Health by 74.5% in the 1st quarter. Intech Investment Management LLC now owns 143,287 shares of the company’s stock worth $4,234,000 after purchasing an additional 61,195 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Hims & Hers Health by 23.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 418,699 shares of the company’s stock worth $12,373,000 after purchasing an additional 78,543 shares during the period. Institutional investors own 63.52% of the company’s stock.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.